-
Je něco špatně v tomto záznamu ?
Changes in activities of circulating MMP-2 and MMP-9 in patients suffering from heart failure in relation to gender, hypertension and treatment: a cross-sectional study
E. Giannakos, E. Vardali, M. Bartekova, M. Fogarassyova, M. Barancik, J. Radosinska
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- antihypertenziva terapeutické užití MeSH
- hypertenze krev komplikace farmakoterapie MeSH
- lidé středního věku MeSH
- lidé MeSH
- matrixová metaloproteinasa 2 krev MeSH
- matrixová metaloproteinasa 9 krev MeSH
- průřezové studie MeSH
- senioři MeSH
- sexuální faktory MeSH
- srdeční selhání krev komplikace MeSH
- studie případů a kontrol MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Matrix metalloproteinases (MMPs) play an important role in the pathogenesis of heart failure (HF). Our aim was to determine the activities of circulating MMP-2 and MMP-9 in patients with HF in respect of gender, comorbidities and treatment (n=51). We did not reveal any differences in circulating pro-MMP-2 and pro-MMP-9 activities between the patients with HF and without it. However, there was a decrease in activity of pro-MMP-2 in treated hypertensive participants versus healthy ones. In contrast, we observed increased pro-MMP-2 activity in hypertensive participants with coexistent HF versus hypertensive participants without HF. In addition, a decrease in pro-MMP-2 activity was shown in women suffering from HF versus men suffering from HF. In conclusion, potential inhibitory effect of antihypertensive treatment on pro-MMP-2 activity was found. Coexistent HF with hypertension probably reduces the inhibitory effect of antihypertensive treatment on pro-MMP-2 activity. Our data also suggest the role of potential cardioprotective factors influencing the activity of pro-MMP-2 in women.
Center of Health Koufalia Thessaloniki Greece
Institute for Heart Research Slovak Academy of Sciences Bratislava Slovak Republic
Institute of Physiology Faculty of Medicine Comenius University in Bratislava Slovak Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17021011
- 003
- CZ-PrNML
- 005
- 20230919125216.0
- 007
- ta
- 008
- 170623s2016 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.933412 $2 doi
- 035 __
- $a (PubMed)27643937
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Giannakos, E. $u Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, Slovak Republic
- 245 10
- $a Changes in activities of circulating MMP-2 and MMP-9 in patients suffering from heart failure in relation to gender, hypertension and treatment: a cross-sectional study / $c E. Giannakos, E. Vardali, M. Bartekova, M. Fogarassyova, M. Barancik, J. Radosinska
- 520 9_
- $a Matrix metalloproteinases (MMPs) play an important role in the pathogenesis of heart failure (HF). Our aim was to determine the activities of circulating MMP-2 and MMP-9 in patients with HF in respect of gender, comorbidities and treatment (n=51). We did not reveal any differences in circulating pro-MMP-2 and pro-MMP-9 activities between the patients with HF and without it. However, there was a decrease in activity of pro-MMP-2 in treated hypertensive participants versus healthy ones. In contrast, we observed increased pro-MMP-2 activity in hypertensive participants with coexistent HF versus hypertensive participants without HF. In addition, a decrease in pro-MMP-2 activity was shown in women suffering from HF versus men suffering from HF. In conclusion, potential inhibitory effect of antihypertensive treatment on pro-MMP-2 activity was found. Coexistent HF with hypertension probably reduces the inhibitory effect of antihypertensive treatment on pro-MMP-2 activity. Our data also suggest the role of potential cardioprotective factors influencing the activity of pro-MMP-2 in women.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a antihypertenziva $x terapeutické užití $7 D000959
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a srdeční selhání $x krev $x komplikace $7 D006333
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypertenze $x krev $x komplikace $x farmakoterapie $7 D006973
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a matrixová metaloproteinasa 2 $x krev $7 D020778
- 650 _2
- $a matrixová metaloproteinasa 9 $x krev $7 D020780
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a sexuální faktory $7 D012737
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vardali, E. $u Center of Health, Koufalia, Thessaloniki, Greece
- 700 1_
- $a Barteková, Monika $7 xx0197134 $u Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, Slovak Republic; Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic
- 700 1_
- $a Fogarassyová, Mária $u Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic $7 xx0307087
- 700 1_
- $a Barančík, Miroslav $7 xx0089695 $u Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic
- 700 1_
- $a Radošínská, Jana $7 _AN048690 $u Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, Slovak Republic; Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic
- 773 0_
- $w MED00003824 $t Physiological research. Advances in cardiovascular research $x 1802-9973 $g Roč. 65, Suppl. 1 (2016), s. S149-S152
- 773 0_
- $t Advances in cardiovascular research $g (2016), s. S149-S152 $w MED00196543
- 856 41
- $u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20170623 $b ABA008
- 991 __
- $a 20230919125213 $b ABA008
- 999 __
- $a ok $b bmc $g 1236307 $s 981884
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 65 $c Suppl. 1 $d S149-S152 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $o Advances in cardiovascular research $x MED00003824
- BMC ##
- $a 2016 $d S149-S152 $m Advances in cardiovascular research $x MED00196543
- LZP __
- $b NLK118 $a Pubmed-20170623